D-0348-2026 Class II Ongoing
FDA drug recall D-0348-2026 was initiated by Wizcure Pharmaa Private Limited on December 31, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. The recall status is ongoing. Affected quantity: 11,520 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- March 4, 2026
- Initiation Date
- December 31, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,520 cartons
Product Description
Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-881, Phase 3, RIICO Industrial Area, Bhiwadi-301019, India, Manufactured for and distributed by: hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260, NDC 77790-003-10.
Reason for Recall
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Distribution Pattern
Distributed Nationwide in the USA
Code Information
All lots